Metagen Therapeutics, Inc.

Metagen Therapeutics, Inc. is a biotechnology startup with a compelling vision captured by their slogan "Make the World Disease-Free." Founded in 2020 and headquartered in Japan, the company operates as a drug discovery and development firm, harnessing the potential of gut microbiome design cultivated in Metabologenomics, Inc. Their focus on creating future businesses with leading microbiome scientists positions them as a significant player in the biotechnology landscape. The most recent milestone for Metagen Therapeutics, Inc. was the ¥600.00M Series A investment secured on 15 June 2023. Notable investors in this round included JAFCO Japan, Nippon Venture Capital, SMBC Venture Capital, Mizuho Capital, JIC Venture Growth Investments, Keio Innovation Initiative, SPARX Asset Management, and Fast Track Initiative, Inc. This substantial investment speaks to the confidence these prominent investors have in the potential of Metagen Therapeutics, Inc.'s innovative approach. The company actively seeks partnerships within the pharmaceutical, healthcare, functional food, and academia sectors, demonstrating their commitment to collaborative growth. For inquiries and potential partnerships, interested parties can reach out to [email protected]. With a strong foundation, strategic location, and significant recent investment, Metagen Therapeutics, Inc. is poised to make a tangible impact in the biotechnology industry.